CURE Pharmaceutical Holding Corp. filed its 10-K on Apr 01, 2022 for the period ending Dec 31, 2021. In this report its auditor, Russell Bedford Stefanou Mirchandani LLP - RBSM LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0331 USD | 0.00% | 0.00% | -55.51% |
1st Jan change | Capi. | |
---|---|---|
-55.51% | 2.42M | |
+7.93% | 85.03B | |
+4.50% | 77.41B | |
-13.28% | 53.89B | |
-22.08% | 47.59B | |
+25.09% | 46.63B | |
+20.34% | 42.81B | |
+63.30% | 37.02B | |
-9.86% | 24.56B | |
+20.07% | 21.72B |
- Stock Market
- Equities
- AVRW Stock
- News Avenir Wellness Solutions, Inc.
- CURE Pharmaceutical Holding Corp. Auditor Raises 'Going Concern' Doubt